1. Academic Validation
  2. Repurposing the Damage Repair Protein Methyl Guanine Methyl Transferase as a Ligand Inducible Fusion Degron

Repurposing the Damage Repair Protein Methyl Guanine Methyl Transferase as a Ligand Inducible Fusion Degron

  • ACS Chem Biol. 2022 Jan 21;17(1):24-31. doi: 10.1021/acschembio.1c00771.
Gosia M Murawska 1 Caspar Vogel 1 Max Jan 2 3 Xinyan Lu 1 Matthias Schild 1 Mikolaj Slabicki 2 3 Charles Zou 2 3 Saule Zhanybekova 1 Manisha Manojkumar 2 3 Georg Petzold 4 Peter Kaiser 5 Nicolas Thomä 4 Benjamin Ebert 2 3 Dennis Gillingham 1
Affiliations

Affiliations

  • 1 Department of Chemistry, University of Basel, 4056 Basel, Switzerland.
  • 2 Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, United States.
  • 3 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, United States.
  • 4 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland.
  • 5 Department of Biological Chemistry, University of California, Irvine, California 92697, United States.
Abstract

We successfully repurpose the DNA repair protein methylguanine methyltransferase (MGMT) as an inducible degron for protein fusions. MGMT is a suicide protein that removes alkyl groups from the O6 position of guanine (O6G) and is thereafter quickly degraded by the ubiquitin Proteasome pathway (UPP). Starting with MGMT pseudosubstrates (benzylguanine and lomeguatrib), we first demonstrate that these lead to potent MGMT depletion while affecting little else in the proteome. We then show that fusion proteins of MGMT undergo rapid UPP-dependent degradation in response to pseudosubstrates. Mechanistic studies confirm the involvement of the UPP, while revealing that at least two E3 ligase classes can degrade MGMT depending on cell-line and expression type (native or ectopic). We also demonstrate the technique's versatility with two clinically relevant examples: degradation of KRASG12C and a chimeric antigen receptor.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-130149
    99.93%, KRAS G12C Inhibitor
    Ras